Indegene Limited — JV/Acquisition, 01-10-2025: Acquisition

Indegene's subsidiary is acquiring 100% equity in BioPharm Parent Holding, Inc. for a total consideration not exceeding USD 106 Million (approx. 8,800 Cr). BioPharm, a US-based marketing and communications agency, specializes in data-driven healthcare provider marketing solutions for Life Sciences clients. This strategic acquisition significantly boosts Indegene's omnichannel marketing capabilities, strengthening its service offerings and expanding its footprint in the crucial North American market. BioPharm reported FY24 revenues of USD 38.13 Million (approx. 316 Cr), indicating a material addition to Indegene's portfolio.